These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8204504)
21. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695 [TBL] [Abstract][Full Text] [Related]
22. Antisense and sensibility. Dove A Nat Biotechnol; 2002 Feb; 20(2):121-4. PubMed ID: 11821852 [No Abstract] [Full Text] [Related]
23. Antisense as a neuroscience tool and therapeutic agent. Estibeiro P; Godfray J Trends Neurosci; 2001 Nov; 24(11 Suppl):S56-62. PubMed ID: 11881747 [TBL] [Abstract][Full Text] [Related]
25. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design. Tabler M; Homann M; Tzortzakaki S; Sczakiel G Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118 [TBL] [Abstract][Full Text] [Related]
26. [RNA in drug development]. Kozu T Tanpakushitsu Kakusan Koso; 2003 Mar; 48(4 Suppl):540-8. PubMed ID: 12696165 [No Abstract] [Full Text] [Related]
28. Cloning strategies for catalytic antisense RNAs. Tabler M; Tsagris M Methods Mol Biol; 1997; 74():121-9. PubMed ID: 9204427 [No Abstract] [Full Text] [Related]
29. Antisense tumor therapy (a dream under construction). Kopper L; Kovalszky I In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725 [TBL] [Abstract][Full Text] [Related]
30. Antisense DNA and RNA agents against picornaviruses. Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540 [TBL] [Abstract][Full Text] [Related]
31. The design of antisense RNA. Sczakiel G Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):439-44. PubMed ID: 9303196 [TBL] [Abstract][Full Text] [Related]
32. Catalytic antisense RNAs produced by incorporating ribozyme cassettes into cDNA. Tabler M; Tsagris M Gene; 1991 Dec; 108(2):175-83. PubMed ID: 1660835 [TBL] [Abstract][Full Text] [Related]
33. Colocalization of antisense RNAs and ribozymes with their target mRNAs. Arndt GM; Rank GH Genome; 1997 Dec; 40(6):785-97. PubMed ID: 9449790 [TBL] [Abstract][Full Text] [Related]
34. Anchoring hairpin ribozymes to long target RNAs by loop-loop RNA interactions. Puerta-Fernández E; Barroso-DelJesus A; Berzal-Herranz A Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):1-9. PubMed ID: 12022685 [TBL] [Abstract][Full Text] [Related]
36. The notorious R.N.A. in the spotlight - drug or target for the treatment of disease. Reautschnig P; Vogel P; Stafforst T RNA Biol; 2017 May; 14(5):651-668. PubMed ID: 27415589 [TBL] [Abstract][Full Text] [Related]
37. Ribozyme and antisense RNAs inhibit coupled transcription translation by binding to rabbit polyribosomes. Denman RB Biochem Biophys Res Commun; 1997 Jan; 230(1):226-31. PubMed ID: 9020052 [TBL] [Abstract][Full Text] [Related]
38. Diastereomeric process control in the synthesis of 2'-O-(2-methoxyethyl) oligoribonucleotide phosphorothioates as antisense drugs. Ravikumar VT; Cole DL Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1639-45. PubMed ID: 14565485 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of HIV-1 replication by RNA targeted against the LTR region. Puerta-Fernández E; Barroso-del Jesus A; Romero-López C; Tapia N; Martínez MA; Berzal-Herranz A AIDS; 2005 Jun; 19(9):863-70. PubMed ID: 15905666 [TBL] [Abstract][Full Text] [Related]
40. Intracellular expression and function of antisense catalytic RNAs. Castanotto D; Scherr M; Rossi JJ Methods Enzymol; 2000; 313():401-20. PubMed ID: 10595369 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]